Apotex Corp. is recalling approximately 2,353 bottles of Sirolimus Oral Solution (1 mg/mL) in 60 mL bottles. The recall was initiated because a specific lot failed dissolution testing, meaning the medication may not dissolve at the required rate to be effective. No incidents or injuries have been reported to date regarding this issue.
The drug failed to meet dissolution specifications during stability testing, which could prevent the medication from being properly absorbed by the body. This failure may reduce the effectiveness of the treatment for patients relying on the medication.
You have 2 options:
Manufactured by Apotex Inc. in Toronto, Canada for Apotex Corp. in Weston, Florida.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.